Xencor | XNCR - Ebit





Ebit Cambiamento Data
AbbVie USD 6.88B 156M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
Arrowhead Research USD -154.34M 13.08M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Cytokinetics USD -167.09M 12.08M 2026-09
GlaxoSmithKline GBP 2.86B 251M 2026-09
J&J USD 6.47B 1B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -65.25M 33.36M 2026-06
Merck USD 7.33B 6.49B 2026-09
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Xencor USD -36.6M 41.26M 2026-06